Track topics on Twitter Track topics that are important to you
NBTY is a leading vertically integrated U.S. manufacturer and distributor of a broad line of high-quality, value-priced nutritional supplements, in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company’s Nature’s Bounty®, Vitamin World®, Puritan’s Pride®, Holland & Barrett®, Rexall®, Sundown®, MET-Rx®, WORLDWIDE Sport Nutrition®, GNC (UK)®, DeTuinen®, LeNaturiste™, SISU®, and Solgar®. For the fiscal third quarter ended June 30, 2006, net sales increased $36 million, or 8%, to $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter ended June 30, 2005. Net income for the fiscal third quarter ended June 30, 2006 was $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005. For the nine months ended June 30, 2006, net sales increased $110 million, or 8%, to $1.4 billion, compared to net sales of $1.3 billion for the prior like period. Net income for the nine months ended June 30, 2006 was $74 million, or $1.07 per diluted share, compared to $67 million, or $0.97 per diluted share for the nine months ended June 30, 2005. At June 30, 2006, NBTY had working capital of $387 million and total assets of $1.3 billion, including $375 million in inventory. Inventory decreased $21 million for the fiscal third quarter of 2006 and decreased $117 million for the nine months ended June 30, 2006. These decreases reflect the Company’s successful initiatives to lower inventory while continuing to assure uninterrupted product supply to its customers. NBTY common stock is traded on the New York Stock Exchange (NYSE) under the symbol “NTY”.
RONKONKOMA, N.Y., Jan. 31, 2013 /PRNewswire/ -- NBTY, Inc. today announced it will webcast a conference call to review its fiscal first quarter results on Wednesday, February 6, 2013 at 9:...
SANTA BARBARA, Calif. and RONKONKOMA, N.Y., June 28, 2013 /PRNewswire-USNewswire/ -- Vitamin World plans to conclude its third successful "Angels for Moms" campaign, to benefit Vitamin Angels, on June...
NORTHRIDGE, Calif., June 30, 2017 /PRNewswire/ -- Pharmavite LLC, one of the largest U.S. manufacturers of high-quality vitamins, minerals and other dietary supplements announced it has appointed Matt...
SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type MonoHerb Type MultiHerb TypeBased on region, the report ...
NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the worl...
NBTY is a leading vertically integrated U.S. manufacturer and distributor of a broad line of high-quality, value-priced nutritional supplements, in the United States and throughout the world. Under a ...
We have published hundreds of NBTY news stories on BioPortfolio along with dozens of NBTY Clinical Trials and PubMed Articles about NBTY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NBTY Companies in our database. You can also find out about relevant NBTY Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...